Boehringer Ingelheim, Icahn School of Medicine at Mount Sinai, Massachusetts General Hospital, Scripps Research Institute, Weill Cornell Medical College deal

Boehringer partnered with the four entities to identify and validate treatments for Crohn’s disease and ulcerative colitis (UC). The pharma and Icahn will research adaptive and innate immune response ...